Board & Committee Resolutions Announcements

The company held its third board of directors' seventh meeting on August 10, 2026. The meeting approved the proposal to convene the second extraordinary general meeting of shareholders in 2026. The general meeting will discuss the purchase of the remaining 49% equity and the company's comprehensive credit line application.

Xi'an Zhongrong Electric Power Co., Ltd. received a designation notice from a customer for its 900V platform electric vehicle battery pack. This marks a significant overseas project win, demonstrating customer recognition of the company's capabilities. The project is expected to contribute positively to future performance, with SOP scheduled for Q4 2028.

This announcement details the opening of three new direct sales stores by Mankalong Jewelry Co., Ltd. in July 2026. The stores are located in Taizhou, Wenzhou, and Chongqing, with planned investments of RMB 400,770, RMB 578,690, and RMB 333,120 respectively. These investments cover initial stocking, renovation, and fixed asset purchases.

The company's fourth board of directors held its ninth meeting via written voting. The board approved the appointment of Sichuan Huaxin (Group) Certified Public Accountants (Special General Partnership) as the company's 2026 auditor and resolved to convene the third extraordinary general meeting of shareholders in 2026.

The Board of Directors of Puni Testing Group Co., Ltd. held its ninth meeting, approving amendments to the Articles of Incorporation, the continued use of idle funds for cash management, and the provision of loans to a subsidiary for investment projects. The meeting also resolved to convene the fourth extraordinary general meeting of shareholders.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announces the completion of the disposal of all shares held under its 2022 Employee Stock Ownership Plan. The plan's assets have been liquidated and distributed, and the plan has been terminated. The company adhered to trading regulations during the plan's implementation.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announces the completion of the cancellation of 641,963 treasury shares from its employee stock ownership plan due to unmet performance targets. This reduces the company's total share capital from 1,212,441,394 to 1,211,799,431 shares. The cancellation is in compliance with regulations and will not materially impact the company's operations or financial status.

Nanjing Pharma-Tech announces progress on its "Quality and Return Improvement" plan. The company reports revenue growth of 15.19% and net profit growth of 37.17% in H1 2026. Key developments include enhanced integrated CRDMO services, expansion of new molecule entity capabilities, and strengthened corporate governance and ESG initiatives. The company also confirmed its 2025 dividend distribution and plans for a 2026 interim dividend.

The announcement details the resolutions passed at the 16th meeting of the Fourth Board of Directors of Nanjing Shiyao Biotechnology Co., Ltd. Key decisions included approving the 2026 interim performance report, the 2026 profit distribution plan, and adjustments to related party transaction forecasts. The meeting also reviewed the progress of the "Quality Return Double Improvement" action plan.

This report details the non-operating fund occupancy and related-party transactions of PharmaBlock Sciences (Nanjing), Inc. for the first half of 2026. The company recorded no non-operating fund occupancy by controlling shareholders or related parties. Total related-party fund transactions amounted to 47.80 million RMB at the end of the period, primarily consisting of operational sales and inter-company funding.

This commitment letter is from an independent director candidate to the Shenzhen Stock Exchange. The candidate pledges to actively participate in the upcoming independent director training organized by the exchange and obtain the recognized qualification certificate. This is a requirement for candidates who have not yet obtained the certificate before the shareholder meeting notice.

The Board of Directors of Happy Blue Sea Film and Television Culture Group Co., Ltd. held its 18th meeting to elect candidates for the 6th Board of Directors. The meeting approved the nomination of non-independent and independent director candidates, and resolved to convene the 2026 First Extraordinary General Meeting.

To thank shareholders for their long-term support, the company is launching a 10th-anniversary shareholder appreciation event. Eligible shareholders can receive free movie vouchers based on their shareholding. The event aims to enhance shareholder engagement and experience company services.

The Compensation and Assessment Committee reviewed the list of grantees for the 2024 Restricted Stock Incentive Plan. Vesting conditions for the second period of the first tranche and the first period of the reserved tranche have been met. A total of 246.20 million shares will be granted to 111 eligible employees.

The Board of Directors of Guangzhou Haoshi Electric Co., Ltd. held its 24th meeting, approving adjustments to the 2024 restricted stock incentive plan's grant price and the cancellation of unvested shares due to employee departures or unmet performance targets. The meeting also confirmed the vesting conditions for the second tranche of the initial grant and the first tranche of the reserved grant.

Henan Qingcaiyuan Technology Co., Ltd. announces its provision for asset and credit impairments totaling RMB 16,960,861.96 for H1 2026. This provision impacts the company's net profit and owner's equity, reflecting a prudent approach to asset valuation. The company's net profit for H1 2026 was RMB -1,759,780.90.

Henan Qingshuiyuan Technology Co., Ltd. has announced a total impairment provision of 16,960,861.96 RMB for the 2026 semi-annual period. This provision includes 15,854,948.76 RMB in credit impairment losses and 1,105,913.20 RMB in asset impairment losses. The company states these provisions are based on prudent accounting principles to reflect its current financial position. This action will reduce the company's total profit and shareholders' equity for the reporting period.

This announcement details the resolutions passed at the 19th meeting of the 6th Board of Directors of Henan QingShuiYuan Technology Co., Ltd. Key decisions included approving the company's 2026 interim report and the provision for asset impairment and credit impairment losses. The meeting confirmed adherence to legal and regulatory requirements.

This report details non-operating fund occupation and other related party fund transactions for Henan Qingyuan Technology Co., Ltd. in H1 2026. The total outstanding balance for non-operating fund occupation was 138,505,519.41 yuan. The company had significant fund occupation and other related party transactions, primarily with subsidiaries.

This draft policy outlines the principles for nominating and appointing board members and employees, emphasizing diversity in gender, age, background, and experience. It aims to enhance corporate governance and development by fostering a balanced board and workforce, with specific targets for gender diversity. The policy will be reviewed annually and reported in the corporate governance report.

Kunlun Tech plans to issue H shares and list on the Hong Kong Stock Exchange to advance its international strategy. The board of directors has approved the proposal. The plan requires shareholder approval and regulatory clearance, with significant uncertainties remaining. Investors are advised to monitor future announcements.

The company's board of directors approved resolutions for issuing H-shares and listing on the Hong Kong Stock Exchange. Key decisions include the type of shares, issuance method, scale, pricing, and use of proceeds for AI technology, business expansion, and strategic investments. The board also approved amendments to company bylaws and the appointment of independent directors.

The Nomination and Remuneration Committee reviewed the list of initial grantees for the 2026 Restricted Stock Incentive Plan. The company conducted internal and external public announcements regarding the list. No objections were received during the announcement period. The committee confirmed that all proposed grantees meet the eligibility criteria.

The company held its 34th Board of Directors meeting to elect new non-independent and independent directors, amend the company's articles of association, and revise governance rules. The meeting also proposed convening the 4th Extraordinary General Meeting of Shareholders for 2026. All proposals were approved by the board.

Zhongdian Environmental Protection Co., Ltd. announced that its 2026 interim report and summary were approved at the fourth meeting of the seventh board of directors. The report will be disclosed on the GEM information disclosure website on August 11, 2026. Investors are advised to review it.

Zhongdian Environmental Protection Co., Ltd. announced the resolutions of its seventh board of directors' fourth meeting. The board approved the 2026 interim report and summary, confirming its information is fair, comprehensive, and accurate. The meeting was convened and conducted in compliance with relevant laws and regulations.

This report details Zhongdian Environmental Protection's non-operating fund occupation and related party transactions for the first half of 2026. It outlines fund flows between the company and its controlling shareholders, former controlling shareholders, and other related parties. The figures indicate significant outstanding balances in non-operating fund occupation and other related party transactions, primarily with subsidiaries.

This announcement details the resolutions from the 19th meeting of the Third Board of Directors of Chenzhan Optoelectronics. Key decisions included the election of Mr. Li Mingfang as Chairman and the adjustment of members for the Audit and Strategy Committees. These changes are effective immediately until the end of the current board term.

Hubei Wufang Optoelectronics Co., Ltd. held its 13th Board of Directors meeting, approving the 2026 semi-annual report and the use of idle funds to purchase wealth management products. The company will invest up to RMB 230 million in wealth management products for up to 12 months, with funds being rolled over.

This report details non-operating fund occupation and other related party fund transactions for Hubei Wufang Optoelectronics Co., Ltd. during the first half of 2026. It outlines fund sources, amounts, interest, repayment, and the nature of these transactions, distinguishing between operating and non-operating activities. The data provides transparency on financial flows with related entities.

Tian Sheng Pharmaceutical announced its wholly-owned subsidiary, Hubei Tian Sheng Pharmaceutical, has passed the consistency evaluation for its Vitamin B6 Injection. This achievement marks a significant step for the company's future generic drug development and provides valuable experience. The company notes potential market and policy uncertainties for pharmaceutical products.

Zhejiang Jiemei Electronic Technology Co., Ltd. explains that parties involved in its proposed share issuance to acquire Changsha Efu Science and Technology Co., Ltd. do not have circumstances that would prohibit them from participating in major asset reorganizations, as per regulatory guidelines. This clarification is made to comply with SZSE rules.

The Board of Directors of Zhejiang Jiemei Electronic Technology Co., Ltd. confirms that the proposed share issuance to acquire 100% of the equity in Changsha Efoes Technology Co., Ltd. complies with relevant regulations. The transaction is deemed fair, beneficial to the company's operations, and does not negatively impact its listing status or independence.

The board of directors of Zhejiang Jiemei Electronic Technology Co., Ltd. explains that the proposed issuance of shares to acquire Changsha Eufos Technology Co., Ltd. complies with Article 11 of the Administrative Measures for the Registration of Issuance of Securities by Listed Companies, confirming no prohibited circumstances exist.

The Board of Directors of Zhejiang Jiemai Electronic Technology Co., Ltd. confirms the independence of the appraisal institution, the reasonableness of appraisal assumptions, the relevance of appraisal methods to the transaction's objectives, and the fairness of the appraisal pricing for the proposed acquisition of Changsha Efoes Technology Co., Ltd. The appraisal results are deemed fair and accurate, protecting shareholder interests.

Independent directors of Zhejiang Jiemei Electronics Co., Ltd. confirm the independence of the appraisal institution, the reasonableness of assumptions, the relevance of methods to the transaction's purpose, and the fairness of the valuation for the proposed acquisition of Changsha Eforces Technology Co., Ltd. The transaction is deemed fair and not detrimental to shareholder interests.

Zhejiang Jiemei Electronics Co., Ltd. clarifies that it has engaged independent financial advisors, legal counsel, auditors, and asset appraisers for its share issuance to acquire Changsha Aifos Technology Co., Ltd. and raise supporting funds. The company confirms these engagements are compliant and that no other compensated third parties are involved.

Zhejiang Jiemei Electronics proposes to issue shares to acquire Changsha Aifu Science and Technology. This announcement explains the potential dilution of immediate returns per share and outlines compensation measures. The company expects increased profits and EPS post-acquisition, but acknowledges potential dilution if the target company underperforms, detailing integration and dividend policies to mitigate risks.

Zhejiang Jiemei Electronic Technology Co., Ltd. proposes to acquire 100% equity in Changsha Aifosi Technology Co., Ltd. The board of directors confirms that the target company has no non-operating fund occupation by shareholders or related parties as of the statement date. Post-acquisition, the target will become a wholly-owned subsidiary and will adhere to the company's policies to prevent such fund occupation.

The company's fifth board of directors held its eighth meeting, approving the issuance of shares to acquire 100% of Changsha Efuosi Technology Co., Ltd. and to raise supporting funds. The acquisition is valued at RMB 915 million. The board also approved related reports and confirmed the transaction does not constitute a major asset restructuring or a backdoor listing.

This document compares the differences between the proposal and the report for Zhejiang Jiemei Electronic Technology Co., Ltd.'s asset acquisition and fundraising plan. It details chapter-by-chapter revisions, including updated transaction summaries, risk disclosures, and financial information. The report reflects changes based on the latest transaction details and regulatory requirements.

This report from Tianjian Certified Public Accountants verifies the authenticity of the performance of the transaction asset, Changsha Ifos Technology Co., Ltd., for the period 2024-March 2026. The audit found no irregularities in revenue recognition, cost transfers, expense recognition, or significant transactions. The auditors concluded that the performance is authentic.

CITIC Securities, as the independent financial advisor, conducted a special due diligence on the performance authenticity of Changsha Efoes Technology Co., Ltd. for the reporting period. The audit confirmed that Efoes Technology's revenue recognition policies comply with accounting standards, and its revenue, cost, and expenses are true, accurate, and complete. The company's performance is deemed authentic and reliable.

CITIC Securities, as the independent financial advisor for Zhejiang Jiemei Electronic Technology Co., Ltd.'s proposed acquisition, confirms it is not subject to any restrictions under regulatory guidelines regarding major asset restructurings. This statement addresses potential concerns about insider trading or regulatory penalties within the last 36 months.

Pan-China Certified Public Accountants commits to the truthfulness, accuracy, and completeness of its professional report for Zhejiang Jiemei Electronic Technology Co., Ltd.'s asset acquisition and fundraising. The firm assures that the report contains no false statements, misleading representations, or material omissions, and it will bear legal responsibility for any such issues.

CITIC Securities, as the independent financial advisor, commits to the truthfulness, accuracy, and completeness of all information disclosed in the application documents for Zhejiang Jiemei Electronic Technology Co., Ltd.'s acquisition of Changsha AifuSi Technology Co., Ltd. The company and its signing personnel will bear joint liability for any misrepresentations or omissions.

Zhejiang Jiemei Electronic Technology Co., Ltd. issues a commitment letter regarding information provided for a share issuance to acquire Changsha Aifosi Technology Co., Ltd. The company guarantees the truthfulness, accuracy, and completeness of all information, documents, statements, and confirmations related to the transaction. This commitment ensures no false records, misleading statements, or material omissions, with legal liability for any breaches.

Zhejiang Jiemei Electronic Technology Co., Ltd. and its controlling shareholders, actual controllers, directors, and senior management commit to not being involved in any prohibited circumstances for major asset restructuring. This includes no insider trading investigations or penalties within the last 36 months. They pledge to maintain confidentiality and bear legal responsibility for any breaches.

The transaction counterparty commits to the truthfulness, accuracy, and completeness of information provided for the acquisition of 100% equity in Efuosi Technology. This includes ensuring document authenticity, timely disclosure of transaction information, and compliance with regulations. In case of misrepresentation leading to losses, the counterparty agrees to bear compensation liability and potential share lock-up.

This document contains commitments from transaction counterparties stating they are not involved in insider trading investigations or have not been penalized for insider trading related to the major asset restructuring. They also commit to maintaining the confidentiality of insider information and not engaging in insider trading.